05-Jun-2008 - Girindus AG

Girindus sells activities in Kuensebeck to Central Glass

Girindus AG sold its industrial activities at the production site in Halle-Kuensebeck. Acquirer is Central Glass Germany GmbH, an affiliate of Central Glass Co., Ltd., Japan. Central Glass Germany GmbH takes over process development, upscaling, cGMP production of active pharmaceutical ingredients as well as the fine chemical business and all related analytical activities. The works council and the employees at the Künsebeck site have been informed immediately. Both parties agreed not to disclose the purchase price.

"With this acquisition we are building the foundation for entering the European market for the contract manufacturing of active pharmaceutical ingredients ", said Masamichi Maruta, Managing Director of Central Glass Germany GmbH.

In addition to maintaining the jobs related to the transferred activities this transaction gives the existing customers continued access to products and services.The separation is associated with a restructuring of the administration functions in Bensberg.

Facts, background information, dossiers
  • Central Glass
  • Girindus
  • services
  • active pharmaceutic…
More about Girindus
More about Central Glass
  • Companies

    Central Glass Germany GmbH

    Central Glass Germany is dedicated to process development, upscaling and production of active ingredients and intermediates for the pharmaceutical and cosmetics industry. It operates a FDA and EU inspected facility in Halle-Kuensebeck. An experienced and highly skilled team of organic chemi ... more

    Central Glass Co., Ltd.

    Central Glass is specialised in the manufacture and sale of flat glass, processed glass, building materials and other glass products; soda, chlorine, organic and inorganic fluorine compounds, fertilizers and other chemical products; glass fiber products; synthetic resins, as well as the pro ... more